NCT00185419View on ClinicalTrials.gov

A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception

PHASE3CompletedINTERVENTIONAL

Enrollment

842

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions

Contraception

Interventions

DRUG

Yasmin

30 µg ethinylestradiol, 3mg drospirenone

DRUG

Marvelon

30 µg ethinylestradiol, 150 µg desogestrel

Trial Locations (1)

Unknown

Ask Contact

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY